Shanghai Chengzhi Zhiyuan Pharmaceutical Technology Co., Ltd. was recently established with a registered capital of 1 billion RMB. The company's business scope includes the development of AI theory, algorithms, and software, as well as AI application software and innovation service platforms. It is wholly owned by Liaoning Chengda Biotechnology Co., Ltd. AI
IMPACT Establishes a new entity focused on AI software development within the pharmaceutical sector.
RANK_REASON Company establishment with AI-related business scope.
- Liaoning Chengda Biotechnology Co., Ltd.
- Li Yeji
- Shanghai Chengzhi Zhiyuan Pharmaceutical Technology Co., Ltd.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →